Skip to main content

Helus Pharma Inc 6-K, filed Nov 16, 2026

Helus Pharma Inc. (HELP)

6-K 2026-11-16 For: 2026-11-16
View Original
Added on November 16, 2026

About this 6-K

Helus Pharma Inc filed this 6-K on November 16, 2026.

Helus Pharma reported positive Phase 3 APPROACH results for HLP003 in adults with major depressive disorder: placebo-adjusted MADRS reductions of -7.6 points at Week 6 and -7.0 points at Week 12, each p<0.0001. AI summary